Ralfinamide |
|
Synonyms: Ralfinamide; (S)-2-(4-(2-fluorobenzyloxy)benzylamino)propanamide; N2-{4-[(2-Fluorobenzyl)oxy]benzyl}-L-alaninamide;NW-1029, FCE-26742A, PNU-0154339E | |
Cat. No.: S00415 | CAS No.: 133865-88-0 |
MDL.: | Formula: C17H19FN2O2 |
F.W.302.34 | Purity: 99% |
Storage: Refrigerator | |
  |
Catalog Number: | S00415 | CAS No.: | 133865-88-0 | |
MDL: | Formula: | C17H19FN2O2 | ||
F.W.: | 302.34 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DCM, Ethyl acetate | Stability: | ||
Storage: | Refrigerator | Category: | Reference Standard | |
Reference: | Bayes, M., et al.: Methods. Find. Exp. Clin. Pharmacol., 27, 411 (2005); Pevarello, P., et al.: J. Med. Chem., 41, 579 (1998); Bauer, M., et al.: Pharmacol., 85, 297 (2010); | |||
Application: | It is a multimodal drug which is under investigation by Newron Pharmaceuticals for the treatment of neuropathic pain and other pain conditions such as post-operative dental pain. | |||
Category: | Aromatics, Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |